Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 +0.99 (+0.95%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

COSM Stock Alert: What to Know As Cosmos’ Reverse Stock Split Takes Effect ↗

December 16, 2022

Cosmos (COSM) stock is on the move Friday as the healthcare company undergoes a name change and a reverse stock split today.

Via InvestorPlace

Scholastic, Maxar Technologies And Some Other Big Stocks Moving Higher On Friday ↗

December 16, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 400 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy? ↗

December 16, 2022

Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing.

Via InvestorPlace

Why Is Exact Sciences (EXAS) Stock Up 23% Today? ↗

December 16, 2022

Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected.

Via InvestorPlace

Dow Drops 200 Points; Accenture Posts Upbeat Results ↗

December 16, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday.

Via Benzinga

Exact Sciences's Return On Capital Employed Insights ↗

November 22, 2022

Via Benzinga

Where Exact Sciences Stands With Analysts ↗

November 08, 2022

Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings within the last quarter:

Via Benzinga

Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results ↗

December 16, 2022

Guardant spent more money than it took in while hoping to become a leader in cancer diagnosis, but accuracy remains a problem.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 16, 2022

Via Benzinga

Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket ↗

December 16, 2022

Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 16, 2022

We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!

Via InvestorPlace

Cathie Wood Adds Another $1M In Tesla After Elon Musk's Stock Sale ↗

December 15, 2022

Cathie Wood-led ARK Investment Management continued to buy Tesla Inc (NASDAQ: TSLA) shares on Thursday with the funds purchasing over 6,000 shares of the EV maker at an estimated valuation of over $1...

Via Benzinga

Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard ↗

December 15, 2022

Exact Sciences' Cologuard has a higher specificity than Guardant's blood test.

Via Investor's Business Daily

After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares? ↗

December 15, 2022

Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 15, 2022

Via Benzinga

Cathie Wood Bought TSLA Stock on the Dip. Should You? ↗

December 15, 2022

Cathie Wood is buying up TSLA stock as Elon Musk sells more of his shares. Here's what this means for Tesla and its investors.

Via InvestorPlace

Stock Futures Are Falling ↗

December 15, 2022

Stock futures fell sharply on Thursday as investors worried that the Federal Reserve’s latest policy update would send the economy into a slump.

Via Talk Markets

10 Health Care Stocks Whale Activity In Today's Session ↗

December 14, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 30, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 28, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

3 Healthcare Stocks That Could Set You Up For Life ↗

November 24, 2022

All offer products that are invaluable to their respective audiences.

Via The Motley Fool

MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences ↗

November 14, 2022

BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares...

Via Benzinga

As Cathie Wood's ARK ETF Surges, These 7 Stocks In The Fund Are Up Over 20% In 5 Days ↗

November 11, 2022

Cathie Wood, the founder, CEO and CIO of ARK Investment Management, has had a tough year in the stock market as all eight of the company's exchange-traded funds (ETFs) were down substantially lower...

Via Benzinga

Cathie Wood's ARK Innovation ETF Marks Record Surge On Thursday: Here's What She Offloaded Amid Market Rally ↗

November 11, 2022

Cathie Wood-owned ARK Investment Management’s flagship fund, the ARK Innovation ETF (NYSE: ARKK) close

Via Benzinga

Expert Ratings for Exact Sciences ↗

November 08, 2022

Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Raymond James Maintains Outperform Rating for Exact Sciences: Here's What You Need To Know ↗

November 08, 2022

Raymond James has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $70.00 to $60.00. Shares of Exact Sciences are trading up 3.28% over the last...

Via Benzinga

SolarEdge To Rally 54%? Plus This Analyst Predicts $1,335 For Mettler-Toledo International ↗

November 08, 2022

Goldman Sachs raised the price target on Mettler-Toledo International Inc. (NYSE: MTD) from $1,120 to $1,335. Goldman Sachs analyst Matthew Sykes upgraded the stock from Sell to Neutral. Mettler-Toledo...

Via Benzinga

Apple To $154? Plus This Analyst Predicts $2,650 For Booking Holdings ↗

November 07, 2022

B of A Securities cut the price target on Apple Inc. (NASDAQ: AAPL) from $160 to $154. Apple shares fell 1.5% to trade at $136.34 on Monday

Via Benzinga

5 Top Stocks Cathie Wood Is Buying This Week ↗

November 04, 2022

Cathie Wood just lauded Elon Musk's acquisition of Twitter, believing the platform will become a "super-app." Here are her top five buys.

Via InvestorPlace

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday ↗

November 07, 2022

Gainers

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.